JHVEPhoto/iStock Editorial via Getty Images Sanofi ( NASDAQ: SNY ) said on Monday it has entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice ((CD&R)) for an enterprise value of €16 billion.
Opella employs over.
